Glaukos Announces Participation in Upcoming Investor Conferences
Glaukos (NYSE: GKOS), a leading ophthalmic pharmaceutical and medical technology company, has announced its participation in two upcoming investor conferences. The company, which specializes in novel therapies for glaucoma, corneal disorders, and retinal diseases, will be present at:
1. The Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, at 12:45 p.m. ET in Boston, MA.
2. The Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024, at 12:20 p.m. ET in New York City, NY.
Glaukos has confirmed that live and archived webcasts of these events, where applicable, will be accessible through the Investors section of their official website at http://investors.glaukos.com.
Glaukos (NYSE: GKOS), un'importante azienda farmaceutica e tecnologica medica oftalmica, ha annunciato la sua partecipazione a due prossime conferenze per investitori. L'azienda, specializzata in nuove terapie per il glaucoma, disturbi corneali e malattie retiniche, sarà presente a:
1. La Wells Fargo Healthcare Conference mercoledì 4 settembre 2024, alle 12:45 ET a Boston, MA.
2. La Morgan Stanley 22esima Conferenza Sanitaria Globale Annuale giovedì 5 settembre 2024, alle 12:20 ET a New York City, NY.
Glaukos ha confermato che le webcasts dal vivo e archiviate di questi eventi, dove applicabile, saranno accessibili tramite la sezione Investitori del loro sito ufficiale all'indirizzo http://investors.glaukos.com.
Glaukos (NYSE: GKOS), una empresa líder en farmacéutica oftálmica y tecnología médica, ha anunciado su participación en dos próximas conferencias para inversionistas. La empresa, especializada en nuevas terapias para el glaucoma, trastornos corneales y enfermedades de la retina, estará presente en:
1. La Conferencia de Salud de Wells Fargo el miércoles 4 de septiembre de 2024, a las 12:45 p.m. ET en Boston, MA.
2. La 22ª Conferencia Anual Global de Salud de Morgan Stanley el jueves 5 de septiembre de 2024, a las 12:20 p.m. ET en Nueva York, NY.
Glaukos ha confirmado que las transmisiones en vivo y los webcasts archivados de estos eventos, cuando sean aplicables, estarán disponibles en la sección de Inversionistas de su sitio web oficial en http://investors.glaukos.com.
글라우코스 (NYSE: GKOS)는 선도적인 안과 제약 및 의료 기술 회사로서 다가오는 두 개의 투자자 회의에 참여한다고 발표했습니다. 안과 질환, 각막 장애 및 망막 질환을 위한 새로운 치료법을 전문으로 하는 이 회사는 다음 회의에 참석할 예정입니다:
1. 웰스 파고 헬스케어 컨퍼런스가 2024년 9월 4일 수요일 오후 12시 45분 ET에 보스턴, MA에서 열립니다.
2. 모건 스탠리 제22회 글로벌 헬스케어 컨퍼런스가 2024년 9월 5일 목요일 오후 12시 20분 ET에 뉴욕시, NY에서 열립니다.
글라우코스는 이러한 이벤트의 실시간 및 보관된 웹캐스트가 가능할 경우 공식 웹사이트의 투자자 섹션을 통해 접근 가능하다고 확인했습니다. 웹사이트 주소는 http://investors.glaukos.com입니다.
Glaukos (NYSE: GKOS), une entreprise leader en pharmacie ophtalmique et technologie médicale, a annoncé sa participation à deux prochaines conférences pour investisseurs. L'entreprise, spécialisée dans les nouvelles thérapies pour le glaucome, les troubles de la cornée et les maladies rétiniennes, sera présente à :
1. La Wells Fargo Healthcare Conference le mercredi 4 septembre 2024, à 12h45 ET à Boston, MA.
2. La 22ème Conférence Annuelle Mondiale sur la Santé de Morgan Stanley le jeudi 5 septembre 2024, à 12h20 ET à New York, NY.
Glaukos a confirmé que les webdiffusions en direct et archivées de ces événements, le cas échéant, seront accessibles via la section Investisseurs de leur site officiel à l'adresse http://investors.glaukos.com.
Glaukos (NYSE: GKOS), ein führendes Unternehmen in der ophthalmologischen Pharmazie und Medizintechnik, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. Das Unternehmen, das sich auf neuartige Therapien für Glaukom, Hornhauterkrankungen und Netzhauterkrankungen spezialisiert hat, wird an folgenden Veranstaltungen teilnehmen:
1. Der Wells Fargo Healthcare Conference am Mittwoch, den 4. September 2024, um 12:45 Uhr ET in Boston, MA.
2. Der 21. Morgan Stanley Annual Global Healthcare Conference am Donnerstag, den 5. September 2024, um 12:20 Uhr ET in New York City, NY.
Glaukos hat bestätigt, dass die Live- und archivierten Webcasts dieser Veranstaltungen, wo anwendbar, über den Abschnitt für Investoren auf ihrer offiziellen Website unter http://investors.glaukos.com zugänglich sein werden.
- None.
- None.
-
Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, at 12:45 p.m. ET in
Boston, MA -
Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024, at 12:20 p.m. ET in
New York City , NY
A live and archived webcast for these events, where applicable, will be available in the Investors section of the Glaukos website at http://investors.glaukos.com.
About Glaukos
Glaukos (www.glaukos.com) is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Glaukos first developed Micro-Invasive Glaucoma Surgery (MIGS) as an alternative to the traditional glaucoma treatment paradigm, launching its first MIGS device commercially in 2012, and continues to develop a portfolio of technologically distinct and leverageable platforms to support ongoing pharmaceutical and medical device innovations. Products or product candidates for each of these platforms are designed to advance the standard of care through better treatment options across the areas of glaucoma, corneal disorders and retinal diseases.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240816901519/en/
Chris Lewis
Vice President, Investor Relations & Corporate Affairs
(949) 481-0510
clewis@glaukos.com
Source: Glaukos Corporation
FAQ
When is Glaukos (GKOS) participating in the Wells Fargo Healthcare Conference?
What time is Glaukos (GKOS) presenting at the Morgan Stanley Global Healthcare Conference?
Where can investors access the webcasts of Glaukos (GKOS) conference presentations?
What types of medical conditions does Glaukos (GKOS) focus on treating?
